BioFire Diagnostics, a subsidiary of French diagnostics outfit bioMérieux, was granted emergency authorization from the FDA for two of its Ebola tests. The company's FilmArray BioThreat-E diagnostic can detect the disease in a blood or urine sample in one hour, beating out current tests which take one to two days to deliver results. The test also forgoes the need for specialized lab processing, as it runs on BioFire lab equipment available in more than 300 U.S. hospitals, Reuters reports. Story | More